An announcement from Aptose Biosciences ( (TSE:APS)) is now available. Aptose Biosciences Inc., a clinical-stage biotech developer of precision oncology drugs focused on hematologic malignancies, is ...
Detailed price information for Marker Therapeutics Inc (MRKR-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results